Navigation Links
GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update
Date:8/19/2007

ATLANTA, Aug. 14 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based biotechnology company (the "Company"), today announced its financial results and provided an operational update for the quarter ended June 30, 2007.

Operating Results for the Quarter Ended June 30, 2007

The Company recorded a net loss of $1,333,126 for the three months ended June 30, 2007, compared to net income of $197,750 for the same period in 2006. For the six months ended June 30, 2007, the Company's net loss was $1,920,407 as compared to a loss of $143,456 in 2006. The increase in the net loss during 2007 is attributable to (a) no grant revenues recorded during 2007 as the Company progressed beyond basic research and into product development activities, (b) higher research and development expenses as the Company continued to support its four ongoing Phase I human clinical trials and prepares for initiation of Phase II studies, and (c) overall higher general and administrative expenses primarily due to the additional costs associated with being a public company subsequent to the merger between Dauphin Technology, Inc. and GeoVax, Inc. in September 2006. As of June 30, 2007, the Company reported cash balances totaling $1,009,302.

See the summarized financial information attached. Further information concerning the Company's financial position and results of operations are included in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission.

Recent Operational Highlights:

* In July, GeoVax announced an early start of two new HIV/AIDS vaccine

clinical (human) trials. These FDA compliant trials were previously

scheduled to start later in 2007 and are the 3rd and 4th in a four

clinical trial series intended to evaluate both human safety and immune

responses to GeoVax's HIV/AIDS vaccines. Starting April 2006, the 1st

of these four trials evaluated a low
'/>"/>

SOURCE GeoVax Labs, Inc.

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Use of the PROTEAN Plus Dodeca Cell for Second-Dimension SDS-PAGE, Rev A
2. In Vitro Measurement of the Second Messenger cAMP: RIA vs. FlashPlate
3. CIOs looking to hire more IT workers in second quarter
4. DNASTAR catches second wave of sequencing
5. 9 tips for making 90 seconds count in an investment pitch
6. City of Hope adds second TomoTherapy system
7. UW-Madison hybrid-vehicle team places second nationally
8. Just one nanosecond: Clocking events at the nanoscale
9. MATCs new computer security program gears up for second semester
10. Weather Central launches second satellite
11. nPoint Secures Second Round of Funding

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...PENHAGEN, Nov. 30 Exiqon A/S (NASD... Harvard Medical School ICCB-Longwood Screening Fa...Screening Center of Excellence. ICCB-L supports i...ated hospitals and institutions, for high-throughp... ,, MicroRNAs are a novel class of small, non-c...
(Date:11/28/2009)...he Vanuatu National Advisory Committee on Climate ...cation (SNC) Project in collaboration with the Van...of New Zealand have generated preliminary climate ...he background for the country’s SNC reportin...imate Change (UNFCCC). , ...
(Date:11/25/2009)....C., Nov. 25 Research Triangle Par...cient, single-treatment water purification system ...dhra Pradesh, Minister of Rural Water Supply, Hon.... India today. Initial tests, performed at Indian I...t the majority of the drinking water available in ...
(Date:11/25/2009)...ING, Nov. 25 /PRNewswire-Asia/ -- Sinovac Biotech ...accines, announced today that it executed,a joint ...n) Vaccine,Technology Co., Ltd. (Sinovac Dalian). ...ialize human-use vaccines. Sinovac will contribute...mmercializing world-class vaccines; the,other part...
Breaking Biology Technology:Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 2Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 3Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 2Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 3Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 4North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, India 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3
...ch 12 , - ThromboGenics Reports Pre-Tax Profi...NV (Euronext Brussels: THR), a biotechnology compa...ovative treatments that will,make a real differenc...utic,areas, is today issuing a business update and...cember 31, 2008. , During the last twelve mont...
...12 Maryland biotech CEOs and companies were honor...ners of the region,s fourth bioscience award compe...s are: , , , , Best New Product or Pr... Osiris Therapeutics, Inc. Mills, Columbia-based...ng stem cell therapies. The funding has allowed O...
...ERT, a leading provider of centralized ECG and eCl... biopharmaceutical, medical device, and related in...ng its portfolio of products and services on Booth...-25 March 2009 in Berlin, Germany. ERT is also inv...will discuss the impact of technology and standard...
Other Biology Technology:ThromboGenics Announces Business Update and 2008 Full Year Results 2ThromboGenics Announces Business Update and 2008 Full Year Results 3ThromboGenics Announces Business Update and 2008 Full Year Results 4ThromboGenics Announces Business Update and 2008 Full Year Results 5ThromboGenics Announces Business Update and 2008 Full Year Results 6Three Firms, Two Training Programs Garner Greater Baltimore Committee's 2009 Bioscience Awards 2ERT to Showcase Its Clinical Trials Portfolio at DIA's 21st Euromeeting 2ERT to Showcase Its Clinical Trials Portfolio at DIA's 21st Euromeeting 3
(Date:11/30/2009)...in the December 2009 print issue of The FASEB Jou...ol over their fertility that women have had since ...w and where androgenic hormones work in the testis...lity. This opens a promising avenue for the develo...fers hope to those who cannot have children becaus...
(Date:11/26/2009)...ut a way of using recordings of birdsong to accura... the first time sound recordings from a microphone...s of bird species, populations. Because the new te...y,s Journal of Applied Ecology , will also work w...n our ability to monitor whale and dolphin numbers...
(Date:11/25/2009)...e California Institute of Technology (Caltech) hav...ehavior in the fruit fly, Drosophila melanogaster...e relationship between the neurotransmitter dopami...DHD), are described in the December issue of the j...ns only about 20,000 neurons and has long been con...
Breaking Biology News(10 mins):Ecologists sound out new solution for monitoring cryptic species 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 4Gut Bacteria Might Be Making People Fat 61167 1Gut Bacteria Might Be Making People Fat 61167 2Gut Bacteria Might Be Making People Fat 61167 3Researchers notch a victory toward new kind of cancer drug 61165 1Researchers notch a victory toward new kind of cancer drug 61165 2Researchers notch a victory toward new kind of cancer drug 61165 3Drug industry nonprofits join forces to fight worlds neglected diseases 61163 1
... are sole proprietors of their nests, some tropica...lps clear up a 150-year-old evolutionary mystery, ...esen. , The Queens-led international study conf...ories first put forward in 1859 and since dispute...e, unhindered, in the same place. Others believe t...
... their successful wastewater fuel cell, researcher...in a new, efficient way. , Bruce Logan and collea...ccess at using microbes to produce electricity. No... be sourced from a salad bar, the researchers have..., By tweaking their design, improving conditions ...
...len spent eight years looking for poison in all th...f the death cap mushroom, Amanita phalloides. The ...ssociate was looking for a big gene that makes a b...s how other fungi produce similar compounds. But a...he big guns new technology that sequences DNA abo...
Other Biology News:'Time-sharing' tropical birds key to evolutionary mystery 2Microbes churn out hydrogen at record rate 2Genetic technology reveals how poisonous mushrooms cook up toxins 2Genetic technology reveals how poisonous mushrooms cook up toxins 3
...ster II Microplate Handler is a high-capacity, plu...rating BioTeks washers, readers and liquid handlin...city, ultimate flexibility and intuitive and power...ingle devices or linking several modules together ...
...e makes your life easier. It offers a wide array o...ement for one balance. *Instruments supported: ... XP, PR, SR, PG-S, PG, SG, AT, MT, UMT, AB-S, PB-S...ce on the balance display *Execute weighings dire...
Goat Anti-XPLAC (S-17) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
...wder ,Components g/500 ml: ,Tryptone 5.0 ,... 6.0 ,S-Gal 0.125 ,Ferric ammonium citrate 0.2...Kanamycin/LB Agar Blend is a complete growth mediu...lactopyranoside, a patented autoclavable chromogen...
Biology Products: